{"prompt": "['Product: MK-3475', '63', 'Protocol/Amendment No.: 604-09', 'Screening', 'End of', 'Follow-up', 'Phase', 'Treatment Phase (3-Week Cycles)', 'Treatment', 'PFS', 'Safety', 'Survival', 'Screening', 'Follow-', 'Treatment Cycle', '1', '1', '1', '2', '2', '2', '3', '3', '3', '4', '4', '4', '5-35', 'Discon\u00b9', 'Follow-', 'Follow-', '(Visit 1)', 'up\u00b2', 'up', 'Visits\u00b3', 'up4', 'Day (in Cycle)', '1', '2&3', '8', '1', '2&3', '8', '1', '2&3', '8', '1', '2&3', '8', '1', 'NA', 'NA', 'NA', 'NA', 'Every 6', 'or 9', '30 Days', 'Weeks', 'At Time of', 'From', 'Every 8', 'Scheduling Window', '-28 to -1', '+3', ' 1', '3', '1', '3', ' 1', '3', '1', '3', 'Last', '( 7', 'Discon', 'Weeks', '(Days):5', '3', 'Dose', 'days)', '7 days', '+ 7', 'per', 'imaging', 'schedule', 'Full Physical Examination', 'X', 'X', 'Directed Physical', 'X', 'X', 'X', 'X', 'Examination', 'Vital Signs', 'X', 'X', 'X', 'X', 'Height and Weight8', 'X', 'X', 'X', '12-Lead ECG', 'X', 'ECOG Performance Status', 'X9', 'X', 'X', 'X', 'Prophylactic Cranial', 'Irradiation10', 'Laboratory Procedures/Assessments: Analysis Performed by Local Laboratory', 'Pregnancy Test - Urine or', 'X', 'Serum \u00df-HCG11', 'PT/INR 12', 'X', 'CBC with Differential12', 'X', 'X', 'X', 'X', 'Comprehensive Chemistry', 'X', 'X', 'X', 'Panel 12', 'Urinalysis12,13', 'X', 'X', 'Thyroid Function', 'X', 'X', 'X', 'Tests 12,14', 'Hepatitis Serologies12', 'X', 'MK-3475-604-09 Final Protocol', '23-Apr-2019', 'Confidential']['Product: MK-3475', '64', 'Protocol/Amendment No.: 604-09', 'Screening', 'End of', 'Follow-up', 'Phase', 'Treatment Phase (3-Week Cycles)', 'Treatment', 'PFS', 'Safety', 'Survival', 'Screening', 'Follow-', 'Treatment Cycle', '1', '1', '1', '2', '2', '2', '3', '3', '3', '4', '4', '4', '5-35', 'Discon\u00b9', 'Follow-', 'Follow-', '(Visit 1)', 'up\u00b2', 'up', 'Visits\u00b3', 'up4', 'Day (in Cycle)', '1', '2&3', '8', '1', '2&3', '8', '1', '2&3', '8', '1', '2&3', '8', '1', 'NA', 'NA', 'NA', 'NA', 'Every 6', 'or 9', '30 Days', 'Weeks', 'At Time of', 'From', 'Every 8', 'Scheduling Window', '-28 to -1', '+3', ' 1', '3', ' 1', '3', '1', '3', '1', '3', '( 7', 'Discon', 'Last', 'Weeks', '(Days):5', '3', 'Dose', 'days)', '7 days', '+7', 'per', 'imaging', 'schedule', 'Analysis Performed by Central Laboratory', 'Blood for Genetic', 'C5D1', 'X', 'X', 'Analysis15', 'only', 'C5D1', 'Blood for RNA Analyses', 'X', 'only', 'Blood for Plasma', 'C5D1', 'X', 'Biomarker Analyses', 'only', 'Blood for Serum', 'C5D1', 'X', 'X', 'Biomarker Analyses', 'only', 'Tumor Tissue Collection', 'Archival or Newly', 'Obtained Tissue', 'X', 'Collection', 'Efficacy Measurements', 'CT/MRI Imaging of', 'Chest, Abdomen, and', 'X', 'X17', 'X17', 'X18', 'X17', 'Pelvis16', 'MRI of Brain\u00b9', 'X', '17,20', 'X17,21', 'X18', 'X', 'Bone Scan22', 'X', 'Survival Status4', 'Subsequent Anti-cancer', 'X', 'X', 'X', 'X', 'Therapies', 'MK-3475-604-09 Final Protocol', '23-Apr-2019', 'Confidential']\n\n###\n\n", "completion": "END"}